Table: Rohto -2020/21 group results

Rohto Pharmaceutical

12/05/2021 07:00

May 12 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            181.29          188.33         182.00                 
                 (-3.7 pct)      (+2.6 pct)     (+0.4 pct)               
  Operating         22.99           23.09          23.10                 
                 (-0.4 pct)      (+10.9 pct)    (+0.5 pct)               
  Recurring         23.91           22.74          23.90                 
                 (+5.2 pct)      (+19.8 pct)    (+0.0 pct)               
  Net
  Net               16.74           15.41          17.10                 
                 (+8.6 pct)      (+57.3 pct)    (+2.1 pct)               
  EPS            146.78 yen      135.13 yen     149.91 yen               
  EPS Diluted    146.36 yen      134.71 yen                              
  Ann Div         28.00 yen       26.00 yen      30.00 yen               
  -Q2 Div         13.00 yen       13.00 yen      15.00 yen               
  -Q4 Div         15.00 yen       13.00 yen      15.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T